Trials / Completed
CompletedNCT03677375
Hemodilution Validation of INVSENSOR00026
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 173 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of a noninvasive hemoglobin sensor will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | INVSENSOR00026 | Noninvasive pulse oximeter sensor |
Timeline
- Start date
- 2018-09-04
- Primary completion
- 2019-02-04
- Completion
- 2019-02-04
- First posted
- 2018-09-19
- Last updated
- 2019-05-20
- Results posted
- 2019-05-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03677375. Inclusion in this directory is not an endorsement.